DY has dropped 11.6% in a single session following its August 26 earnings print — extending a brutal week to -22.8% and a monthly drawdown of -27.7%. Yet the signals beneath the surface are moving in an unexpected direction.
The put/call ratio crashed to 0.56 on August 26. That is 2.1 standard deviations below the 20-day mean of 0.74 — the most call-heavy reading in months. Context matters here: a stock down 11% in a day would normally trigger a wave of protective put buying. Instead, the ratio moved the other way. This is an unusual divergence. The PCR sat above 1.2 in late July. It has collapsed in a straight line since.
The previous note filed yesterday observed the PCR at 0.68, noting the pre-earnings call skew was fading. It has since accelerated further into call territory, not reverted.
Short interest dropped 13.8% in a single day, landing at 4.5% of free float as of August 25. That is a significant cover — around 207,000 shares returned to the pool in one session. The cover happened the earnings drop, not after. Short sellers reduced exposure into the print, not on the weakness.
The borrow market reflects that. Availability sits at 1,971% of outstanding short interest — roughly 28.6 million shares available against 1.3 million currently borrowed. The lending market is extremely loose. Cost to borrow has ticked up to 0.40% — elevated versus a week ago but still low in absolute terms. There is no squeeze pressure building here.
The consensus price target is $593. The stock trades at $310.91. That is a 91% implied gap between where analysts point and where the market sits. All six analyst actions on record since May maintained Overweight or Buy ratings with targets between $610 and $654. None of those targets have been revised since the print landed.
The analyst community has not caught up. Either the targets collapse in the coming days, or the post-earnings reaction is being read as excessive.
See the live data behind this article on ORTEX.
Open DY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
